MedTrace Logo

Retrospective Review of Esophageal Cancer at MSKCC

NCT05706558 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 4000

Last updated 2026-03-09

No results posted yet for this study

Summary

Residual tumor at the proximal or distal margin after esophagectomy is a known prognostic factor for poor survival outcomes in patients with esophageal cancer; however, the significance of the circumferential resection margin (CRM) remains controversial. In this study, the investigators sought to evaluate the prognostic significance of the CRM in patients with esophageal cancer undergoing resection.

Conditions

  • Esophageal Cancer
  • Esophagus Cancer

Interventions

PROCEDURE

Esophagectomy

Esophagectomy

Sponsors & Collaborators

Principal Investigators

  • Daniela Molena, MD · Memorial Sloan Kettering Cancer Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-12-13
Primary Completion
2027-02-28
Completion
2027-02-28

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05706558 on ClinicalTrials.gov